Mon, Dec 29, 2014, 10:06 AM EST - U.S. Markets close in 5 hrs 54 mins

Recent

% | $
Quotes you view appear here for quick access.

InVivo Therapeutics Holdings Corp. Message Board

weitzwb24 3 posts  |  Last Activity: Nov 5, 2014 7:19 PM Member since: Feb 5, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • One complaint withdrawn, class action lawsuit still pending.

    In June 2014, Mr. Reynolds filed a complaint with the Massachusetts Commission Against Discrimination (MCAD) alleging that we discriminated against him on the basis of physical disability in violation of Massachusetts law and the Americans with Disability Act. We filed a written response to the complaint denying the claim. Mr. Reynolds withdrew his MCAD complaint on September 15, 2014.

    On July 31, 2014, a putative securities class action lawsuit was filed in the United States District Court for the District of Massachusetts, naming our Company and Mr. Reynolds, as defendants. The lawsuit alleges violations of the Securities Exchange Act of 1934 in connection with allegedly false and misleading statements related to the timing and completion of the clinical study of our Scaffold product. The plaintiff seeks class certification for purchasers of our common stock during the period from April 5, 2013 through August 26, 2013 and unspecified damages. The Company intends to vigorously defend the lawsuit.

    Sentiment: Strong Buy

  • Reply to

    But But But...

    by davidf104 Oct 22, 2014 4:55 PM
    weitzwb24 weitzwb24 Oct 22, 2014 11:11 PM Flag

    david some of us do not day trade. My average is low.... I have no plans on selling a while. Why would I sell at $1 knowing a pullback is coming to try and get back in at $0.90. If I sell at $5 I am up either way.....

    I could wait the 3 day settlement period and miss an announcement that takes this to $1.5.

    You have to see both sides..... (I know feeding the troll)

    Sentiment: Strong Buy

  • weitzwb24 weitzwb24 Oct 21, 2014 7:11 PM Flag

    Voisybay this is false.

    The primates have had trials with scaffold alone with positive results.

    The trails are very clearly outlined in the 10-K from 3/15/2012. (Yes I have been reading SEC filings since 2011 or so....)

    The most recent trial from 2011 there were no tests done with neural stem cells.

    Sentiment: Strong Buy

NVIV
1.45+0.01(+0.69%)9:49 AMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.